课题基金 / 基金详情

Developing a pathogen-repellant wrap-improving performance and manufacturing throughput and evaluating real-world potential

Developing a pathogen-repellant wrap-improving performance and manufacturing throughput and evaluating real-world potential
开发一种病原体防护包装——提高性能和制造产量并评估现实世界的潜力
批准号:
570921-2021
负责人:
Soleymani, LeylaL
金额:
$13.26万
依托单位:
依托单位国家:
加拿大
项目类别:
Alliance Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31

项目摘要

项目成果

Soleymani, LeylaL的其他基金

相似基金

相关文献

中文摘要
翻译
我们开发了一种可用于各种表面以减少污染的病原体排斥性柔性包裹物RepelWrap。RepelWrap是建立在结构层次,精心设计的功能,从纳米级到宏观尺度,结合化学功能化,以实现广泛的液体和病原体排斥。RepelWrap将表面上的病毒污染减少了4个对数,并将细菌生物膜的形成减少了85%。在这个项目中,我们将与加拿大三家积极开展研发活动的行业合作伙伴合作,通过设计一种新的双功能材料架构,提高RepelWrap的病原体排斥性。(与FendX合作),使用卷对卷处理而不是手动沉积来提高生产量(与FendX和FLEXcon合作),并评估RepelWrap在真实条件下的病原体排斥性(与Draganfly合作)。 该项目的最终成果将是一种高效的抗菌表面,将表面上的细菌和病毒载量减少至少3个对数。 凭借本文中开发的知识和材料,FendX打算将RepelWrap商业化,面向加拿大和全球市场,创造研发和供应链就业机会。 FLEXcon是RepelWrap的预期制造商,它将使用在此赠款中开发的加工知识在其加拿大制造工厂制造该产品,创造制造业就业机会。Draganfly预计将使用RepelWrap作为包装和保护材料,以减少感染的传播。RepelWrap将提供一种加拿大制造的解决方案,以减少诸如SARS-CoV-2、耐甲氧西林金黄色葡萄球菌和铜绿假单胞菌等令人担忧的病原体的传播,通过减少传染病的负担提供重要的健康益处。
英文摘要
We have developed, RepelWrap, a pathogen-repellent flexible wrap that can be applied to a wide range of surfaces for reducing contamination. RepelWrap is founded on structural hierarchy, carefully designed features from the nanoscale to the macroscale, combined with chemical functionalization for achieving wide-range liquid and pathogen repellency. RepelWrap reduces viral contamination on surfaces by 4-logs and the formation of bacterial biofilms by 85%. There is a tremendous market need for such technology that can be applied to high touch surfaces and packaging for reducing the spread of infectious pathogens.In this project, we will partner with three industry partners with active research and development activities in Canada to improve the pathogen repellency of RepelWrap by engineering a new bi-functional materials architecture (in collaboration with FendX), enhance manufacturing throughput using roll-to-roll processing rather than manual deposition (in collaboration with FendX and FLEXcon), and to assess the pathogen repellency of RepelWrap under real-world conditions (in collaboration with Draganfly). The final outcome of this project will be a highly effective antimicrobial surface, reducing bacterial and viral loads on surfaces by at least 3-logs. With the knowledge and materials developed herein, FendX intends to commercialize RepelWrap for the Canadian and global market, creating research and development, and supply chain jobs. FLEXcon is the intended manufacturer for RepelWrap, and it will use the processing knowledge developed in this grant to manufacture this product at their Canadian manufacturing facility, creating manufacturing jobs. Draganfly is expected to use RepelWrap as a packaging and protective material for reducing the transmission of infections. RepelWrap will provide a made in Canada solution for reducing the spread of pathogens of concern such as SARS-CoV-2, methicillin-resistant staphylococcus aureus, and Pseudomonas aeruginosa, to name a few, providing important health benefits by reducing the burden of infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Market translation of a rapid aptamer-based COVID-19 saliva test
  • 批准号:
    571001-2022
  • 项目类别:
    Idea to Innovation
  • 资助金额:
    $25.38万
  • 财政年份:
    2022
  • 负责人:
    Soleymani, LeylaL
  • 依托单位:
Fully integrated biosensing platform-integrating blood/plasma separation, digital microfluidics, and electrochemistry
  • 批准号:
    570448-2021
  • 项目类别:
    Alliance Grants
  • 资助金额:
    $11.67万
  • 财政年份:
    2022
  • 负责人:
    Soleymani, LeylaL
  • 依托单位:
国内基金
海外基金
基于质谱贴片的病原菌标志物检测及伤口感染诊断应用
  • 批准号:
    82372148
  • 项目类别:
    面上项目
  • 资助金额:
    60.00万元
  • 批准年份:
    2023
  • 负责人:
    黄琳
  • 依托单位:
基于纳米金属有机框架(MOFs)荧光生物探针的病原微生物(Pathogen)高灵敏电化学快速检测方法研究
  • 批准号:
    31870078
  • 项目类别:
    面上项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2018
  • 负责人:
    刘坤平
  • 依托单位:
“寒淫”轻重强度致病及转归的转录组与代谢组整合研究
  • 批准号:
    30873212
  • 项目类别:
    面上项目
  • 资助金额:
    28.0万元
  • 批准年份:
    2008
  • 负责人:
    陈康
  • 依托单位: